A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.
Saved in:
| Title: | A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy. |
|---|---|
| Authors: | Gambaro, Karen1,2,3 (AUTHOR) kgambaro@exactis.ca, Marques, Maud1,3 (AUTHOR) mmarques@exactis.ca, McNamara, Suzan1,2 (AUTHOR) smcnamara@exactis.ca, Couetoux du Tertre, Mathilde1,2 (AUTHOR), Hoffert, Cyrla1,2,3 (AUTHOR), Srivastava, Archana1,2,3 (AUTHOR), Schab, Anna1,2 (AUTHOR), Alcindor, Thierry4 (AUTHOR), Langleben, Adrian5 (AUTHOR), Sideris, Lucas6 (AUTHOR), Abdelsalam, Mahmoud7 (AUTHOR), Tehfe, Mustapha8 (AUTHOR), Couture, Felix9 (AUTHOR), Batist, Gerald3 (AUTHOR) gerald.batist@mcgill.ca, Kavan, Petr3 (AUTHOR) gerald.batist@mcgill.ca |
| Source: | International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p43. 23p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16616596 |
|---|---|
| DOI: | 10.3390/ijms25010043 |
